Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Mar 26;9(3):1768-1771.
doi: 10.4103/jfmpc.jfmpc_972_19. eCollection 2020 Mar.

Waldenstrom's Macroglobulinemia: A case report

Affiliations
Case Reports

Waldenstrom's Macroglobulinemia: A case report

Nejima Kolikkat et al. J Family Med Prim Care. .

Abstract

Waldenstrom's macroglobulinemia (WM) is a rare and slowly progressive disorder, a variant of lymphoplasmacytic lymphoma, which needs therapy only when patient becomes symptomatic. WM presents usually with constitutional symptoms, organomegaly, cytopenias, and hyperviscosity syndrome. This neoplasm is composed of small lymphocytes, plasmacytoid lymphocytes, and plasma cells that typically involve the bone marrow, and it is associated with an immunoglobulin M (IgM) gammopathy. Here we report the case a 60-year-old male with WM who initially presented with anemia and fatigue. The patient had no lymphadenopathy or any organomegaly. The diagnosis of WM was made after morphological and immunohistochemical examination of bone marrow of the patient along with an elevated serum IgM level. The patient responded well to plasmapheresis and chemotherapy. This case is unusual because the patient lacked the common clinical features of WM. A thorough clinical and hematological work up including serum electrophoresis, bone marrow study, and immunohistochemistry helps in distinguishing WM from other lymphomas and plasma cell dyscrasias.

Keywords: Immunoglobulin M monoclonal gammopathy; Waldenstrom macroglobulinemia; lymphoplasmacytic.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Bone marrow biopsy showing erythroid hyperplasia, plasmacytosis and scattered mononuclear lymphoid cells
Figure 2
Figure 2
Showing immunohistochemistry showing cells positive for CD20
Figure 3
Figure 3
Showing immunohistochemistry showing cells positive for CD138

References

    1. Costa PZ, Chorão P, Póvoa A, Vieira P, Cabrera H, Mendes O, et al. Waldenström macroglobulinemia and cerebral venous thrombosis:From diagnosis to complication. Case Rep Med. 2019;2019:3. Article ID 9581605. doi:10.1155/2019/9581605. - PMC - PubMed
    1. Arjunan A, Rai H. Central nervous system involvement by Waldenstrom macroglobulinemia:A case report of the Bing-Neel syndrome. Case Rep Hematol. 2019;2019:3. Article ID 4075960. doi:10.1155/2019/4075960. - PMC - PubMed
    1. Gertz MA. Waldenstrom macroglobulinemia:2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017;92:209–17. - PubMed
    1. Sethi B, Butola KS, Kumar Y. A diagnostic dilemma:Waldenström's macroglobulinemia/plasma cell leukemia. Case Rep Pathol. 2012;2012:271407. - PMC - PubMed
    1. Waldenstrom J. Incipient myelomatosis or “essential“hyperglobulinemia with fibrinognenopenia—A new syndrome? Acta Med Scand. 1944;117:216–47. doi:10.1111/j 0954-6820.1944.tb03955.x.

Publication types